Mechanism of Yi-xin-yin oral liquid according to homotherapy for heteropathy theory based on UHPLC-Q-TOF/MS combined with network pharmacology and molecular docking techniques
10.12092/j.issn.1009-2501.2024.01.002
- Author:
Yejian WANG
1
;
Juan LI
1
;
Weidong CHEN
1
;
Feng ZHANG
1
;
Yejian WANG
2
;
Tao PANG
2
;
Jie GAO
2
;
Wansheng CHEN
2
;
Feng ZHANG
2
;
Guangyang JIAO
3
;
Wansheng CHEN
3
;
Nan WENG
4
Author Information
1. School of Pharmacy, Anhui University of Chinese Medicine
2. Department of Pharmacy, Changzheng Hospital, Naval Medical University, Second Military Medical University
3. School of Pharmacy, Research and Development Center of Chinese Medicine Resources and Biotechnology, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine
4. School of Traditional Chinese Material, Shenyang Pharmaceutical University
- Publication Type:Journal Article
- Keywords:
arrhythmia;
heart failure;
homotherapy for heteropathy;
molecular docking;
myocarditis;
network pharmacology;
UHPLC-Q-TOF/MS;
Yi-xin-yin oral liquid
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2024;29(1):11-25
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To predict the core targets and related signaling pathways of Yi-xin-yin oral liquid for the treatment of arrhythmia, heart failure and myocarditis based on UHPLC-Q-TOF/MS, network pharmacology, molecular docking methods, cell experiments, according to the“homotherapy for heteropathy”theory in traditional Chinese medicine. METHODS: UHPLC-Q-TOF / MS was used to analyze and identify the chemical composition of Yi-xin-yin oral liquid Extract and the blood-absorbing components of rats oral administrated with Yi-xin-yin oral liquid extract, which compounds were applied in the databases searching for the potential targets (TCMSP, SwissTargetPrediction) and disease targets (OMIM, Genecard). Venn diagram was used for target intersection, and the subsequent protein-protein interaction network obtained core targets by STRING11.5 database, and then construct a "disease-component-target" network by cytoscape3.9.0. Finally, DAVID database was used to analysis GO function and KEGG enrichment analysis of core targets, and molecular docking validation was performed using Autodock vina software. And, validated with H9c2 cells for potential active ingredients and targets. RESULTS: A total of 156 compounds were identified from Yi - xin-yin Oral Liquid extract; 34 compounds were identified from rat serum, including 6-gin-gerol, isoliquiritigenin, glycyrrhizic acid and other compounds, and 139 intersecting targets were obtained. The KEGG pathway enrichment analysis mainly involved the TNF signaling pathway, IL-17 signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway and so on. The TNF and IL-6 targets were selected for molecular docking with the main compounds, and the docking results were good (less than -5 kcal/mol). In vitro cellular experiments have shown that Yi-xin-yin oral liquid can exert therapeutic effects by regulating TNF and IL-6. CONCLUSION: The main potential active ingredients of Yi-xin-yin oral liquid may be isoliquiritigenin, glycyrrhetinic acid, calycosin-7-glucoside, salvianolic acid B, and 6-gingerol, which mainly act on TNF, IL-6 and other targets to regulate specific signaling pathways and exert therapeutic effects.
